BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14

• Press Releases

  YD Bio Highlights Peer-Reviewed Publication on New Computational Framework for Keratoconus Research

  August 4, 2026

   · 

  5 min read
• Press Releases

  SHY Therapeutics Announces the First Patient Has Been Dosed in Phase 1 Clinical Trial Evaluating SHY-ONC6, a Novel, Oral Proteasome Inhibitor for the Treatment of Solid Tumors

  August 4, 2026

   · 

  3 min read
• Press Releases

  IPG Photonics Announces Second Quarter 2026 Financial Results

  August 4, 2026

   · 

  19 min read
• Press Releases

  Altasciences Completes Expansion of Research and Development Laboratory in Harleysville, Pennsylvania

  August 4, 2026

   · 

  2 min read
• Press Releases

  Forlong Biotechnology Announces Approval to Initiate Phase I Clinical Trial of FL115 (IL-15 Superagonist) Subcutaneous Injection in Australia

  August 4, 2026

   · 

  3 min read
• Press Releases

  Quanterix To Report Second Quarter 2026 Financial Results on August 10, 2026

  August 4, 2026

   · 

  1 min read
• Press Releases

  Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - August 4, 2026

  August 4, 2026

   · 

  2 min read
• Press Releases

  CEL-SCI Study Published in Peer-Reviewed Oral Oncology Supports Multikine’s Biomarker Strategy and Potential Overall Survival Benefit Ahead of Head and Neck Cancer Confirmatory Registration Study

  August 4, 2026

   · 

  6 min read
• 

  Business

  As portfolio erodes, BMS stands to gain a lot from rumored AstraZeneca merger

  While both drugmakers face looming patent cliffs, analysts say joining forces could help Bristol Myers Squibb replenish its eroding portfolio—while the strategic case for AstraZeneca seems to be more mixed.

  August 4, 2026

   · 

  3 min read

   · 

  Gabrielle Masson
• Press Releases

  Akari Therapeutics Releases CEO Corner Highlighting Strategic WhiteHawk Collaboration and the Expanding Opportunity for Dual-Payload ADC Innovation

  August 4, 2026

   · 

  7 min read